Table 2.
Distribution of rs1051730 in the overall study population and stratified by smoking status
| Genotype | CC | CT | TT |
|---|---|---|---|
| All genotyped subjects n = 26 471 (%) | 12 092 (45.7) | 11 442 (43.2) | 2937 (11.1) |
| Analysed subjectsa n = 24 794 (%) | 11 311 (45.6) | 10 732 (43.3) | 2751 (11.1) |
| Current smokers n = 6951 (%) | 3109 (44.7) | 3041 (43.8) | 801 (11.5) |
| Previous smokers n = 8426 (%) | 3916 (46.5) | 3611 (42.9) | 899 (10.7) |
| Never smokers n = 9417 (%) | 4286 (45.5) | 4080 (43.3) | 1051 (11.2) |
aWith complete data for age, sex, rs1051730, body mass index, smoking status, hypertension and lipid‐lowering treatment.